JNBA Financial Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $540K | Buy |
450
+2
| +0.4% | +$2.04K | 0.04% | 139 |
|
|
2026
Q1 | $412K | Sell |
448
-1
| -0.2% | -$1.01K | 0.03% | 146 |
|
|
2025
Q4 | $483K | Buy |
449
+5
| +1% | +$4.78K | 0.04% | 144 |
|
|
2025
Q3 | $339K | Buy |
444
+1
| +0.2% | +$744 | 0.03% | 155 |
|
|
2025
Q2 | $345K | Hold |
443
| – | – | 0.03% | 149 |
|
|
2025
Q1 | $366K | Sell |
443
-56
| -11% | -$46.6K | 0.04% | 145 |
|
|
2024
Q4 | $385K | Hold |
499
| – | – | 0.04% | 144 |
|
|
2024
Q3 | $442K | Hold |
499
| – | – | 0.04% | 134 |
|
|
2024
Q2 | $452K | Sell |
499
-130
| -21% | -$104K | 0.05% | 134 |
|
|
2024
Q1 | $489K | Buy |
629
+229
| +57% | +$163K | 0.05% | 133 |
|
|
2023
Q4 | $233K | Sell |
400
-116
| -22% | -$67.7K | 0.03% | 185 |
|
|
2023
Q3 | $277K | Sell |
516
-32
| -6% | -$16.5K | 0.03% | 169 |
|
|
2023
Q2 | $257K | Buy |
548
+4
| +0.7% | +$1.68K | 0.03% | 176 |
|
|
2023
Q1 | $187K | Buy |
544
+4
| +0.7% | +$1.35K | 0.02% | 191 |
|
|
2022
Q4 | $198K | Hold |
540
| – | – | 0.03% | 187 |
|
|
2022
Q3 | $175K | Sell |
540
-59
| -10% | -$18.7K | 0.03% | 191 |
|
|
2022
Q2 | $194K | Sell |
599
-29
| -5% | -$8.71K | 0.03% | 182 |
|
|
2022
Q1 | $180K | Hold |
628
| – | – | 0.02% | 194 |
|
|
2021
Q4 | $173K | Buy |
628
+88
| +16% | +$22.3K | 0.02% | 201 |
|
|
2021
Q3 | $125K | Hold |
540
| – | – | 0.02% | 217 |
|
|
2021
Q2 | $124K | Hold |
540
| – | – | 0.02% | 215 |
|
|
2021
Q1 | $101K | Buy |
540
+30
| +6% | +$5.87K | 0.01% | 221 |
|
|
2020
Q4 | $86K | Hold |
510
| – | – | 0.01% | 219 |
|
|
2020
Q3 | $75K | Hold |
510
| – | – | 0.02% | 211 |
|
|
2020
Q2 | $84K | Sell |
510
-200
| -28% | -$30.7K | 0.02% | 200 |
|
|
2020
Q1 | $98K | Sell |
710
-83
| -10% | -$11.4K | 0.02% | 178 |
|
|
2019
Q4 | $104K | Buy |
793
+193
| +32% | +$22.4K | 0.02% | 181 |
|
|
2019
Q3 | $67K | Sell |
600
-200
| -25% | -$22.3K | 0.01% | 204 |
|
|
2019
Q2 | $89K | Buy |
800
+100
| +14% | +$11.8K | 0.02% | 188 |
|
|
2019
Q1 | $91K | Hold |
700
| – | – | 0.02% | 181 |
|
|
2018
Q4 | $81K | Sell |
700
-1,100
| -61% | -$123K | 0.02% | 172 |
|
|
2018
Q3 | $193K | Buy |
1,800
+1,100
| +157% | +$110K | 0.09% | 130 |
|
|
2018
Q2 | $60K | Hold |
700
| – | – | 0.01% | 209 |
|
|
2018
Q1 | $54K | Hold |
700
| – | – | 0.01% | 215 |
|
|
2017
Q4 | $59K | Sell |
700
-300
| -30% | -$25.5K | 0.01% | 209 |
|
|
2017
Q3 | $86K | Buy |
1,000
+300
| +43% | +$24.6K | 0.02% | 174 |
|
|
2017
Q2 | $58K | Hold |
700
| – | – | 0.01% | 194 |
|
|
2017
Q1 | $59K | Hold |
700
| – | – | 0.01% | 191 |
|
|
2016
Q4 | $51K | Sell |
700
-1,331
| -66% | -$99.1K | 0.01% | 207 |
|
|
2016
Q3 | $163K | Buy |
2,031
+1,331
| +190% | +$107K | 0.02% | 264 |
|
|
2016
Q2 | $55K | Sell |
700
-65
| -8% | -$4.89K | 0.02% | 194 |
|
|
2016
Q1 | $55K | Buy |
765
+65
| +9% | +$4.92K | 0.02% | 188 |
|
|
2015
Q4 | $59K | Hold |
700
| – | – | 0.02% | 180 |
|
|
2015
Q3 | $59K | Hold |
700
| – | – | 0.03% | 169 |
|
|
2015
Q2 | $58K | Hold |
700
| – | – | 0.02% | 170 |
|
|
2015
Q1 | $51K | Hold |
700
| – | – | 0.02% | 188 |
|
|
2014
Q4 | $48K | Hold |
700
| – | – | 0.02% | 195 |
|
|
2014
Q3 | $45K | Hold |
700
| – | – | 0.02% | 202 |
|
|
2014
Q2 | $44K | Hold |
700
| – | – | 0.02% | 188 |
|
|
2014
Q1 | $41K | Hold |
700
| – | – | 0.02% | 181 |
|
|
2013
Q4 | $36K | Hold |
700
| – | – | 0.02% | 185 |
|
|
2013
Q3 | $35K | Hold |
700
| – | – | 0.02% | 178 |
|
|
2013
Q2 | $34K | Buy |
+700
| New | +$38.1K | 0.02% | 167 |
|
Other funds holding LLY
SC
ONB
GIM
JNBA Financial Advisors's LLY Position: Q2 2026 in Review
JNBA Financial Advisors increased its Eli Lilly (LLY) stake by 0.45% in Q2 2026, buying an estimated $2.04K and bringing the position to 450 shares worth $540K. The position accounts for 0.04% of the portfolio, ranked #139.
JNBA Financial Advisors first reported a position in LLY in Q2 2013 and has held it in 53 quarters since. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- JNBA Financial Advisors held 450 shares of Eli Lilly worth $540K as of Q2 2026.
- JNBA Financial Advisors bought 2 Eli Lilly shares in Q2 2026, an estimated $2.04K.
- Eli Lilly made up 0.04% of JNBA Financial Advisors's portfolio in Q2 2026, its #139 holding.
- JNBA Financial Advisors first reported a position in Eli Lilly in Q2 2013 and has held it in 53 quarters since.
- 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on JNBA Financial Advisors's 13F filing for Q2 2026, filed 23 Jul 2026.